placeholder image
J. Mak All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Estimated effectiveness of 2024-2025 COVID-19 vaccines in adults. 
    JAMA internal medicine. 2026
  • Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. 
    Vaccine. 2026
  • Interim estimated effectiveness of 2025-2026 COVID-19 vaccines in adults using a test-negative design. 
    JAMA network open. 2026
  • Effectiveness of 2024-2025 COVID-19 vaccines in children in the United States - VISION, August 29, 2024-September 2, 2025. 
    MMWR: Morbidity and Mortality Weekly Report. 2025
  • Estimated 2023-2024 COVID-19 vaccine effectiveness in adults. 
    JAMA network open. 2025
  • Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024. 
    Clinical Infectious Diseases. 2025
  • Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. 
    Lancet (London, England). 2024
    • Contact
    full name
  • J. Mak
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration